Cargando…
Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms
PURPOSE: The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the possible impact of a wide range of social, economic, and medical factors on compliance w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Continence Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083827/ https://www.ncbi.nlm.nih.gov/pubmed/27706009 http://dx.doi.org/10.5213/inj.1632520.260 |
_version_ | 1782463290056638464 |
---|---|
author | Kosilov, Kirill Vladimirovich Alexandrovich, Loparev Sergay Gennadyevna, Kuzina Irina Viktorovna, Shakirova Olga Sergeevna, Zhuravskaya Natalia Ivanovich, Ankudinov Ivan |
author_facet | Kosilov, Kirill Vladimirovich Alexandrovich, Loparev Sergay Gennadyevna, Kuzina Irina Viktorovna, Shakirova Olga Sergeevna, Zhuravskaya Natalia Ivanovich, Ankudinov Ivan |
author_sort | Kosilov, Kirill Vladimirovich |
collection | PubMed |
description | PURPOSE: The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the possible impact of a wide range of social, economic, and medical factors on compliance with solifenacin treatment in the working population. METHODS: Social, economic, and medical factors as well as the Overactive Bladder questionnaire – the OAB-q Short Form (OAB-q SF), bladder diaries, and uroflowmetry of 1,038 people who were administered solifenacin for a year were gathered from employer documentation. RESULTS: Among the subjects, 32% maintained their compliance with solifenacin treatment throughout the year. Only 65% of the patients had compliance exceeding 80%, and 17% of patients had compliance of ≥50%, yet less than 80% were still taking solifenacin 12 months after the beginning of this experiment. Working people whose compliance level was, at least, 80% had reliably higher (P≤0.01) average age, annual salary, and treatment efficacy, and a greater treatment satisfaction level, as well as a lack of satisfaction with other antimuscarinic treatments and higher rate of urge UI diagnosis. The same cohort also featured a lower level (P≤0.01) of caffeine abuse and lower share of salary spent purchasing solifenacin. CONCLUSIONS: This study has shown that compliance with solifenacin treatment is associated with a number of significant medical, social, and economic factors. The medical factors included the type of urination disorder, severity of incontinence symptoms, presence of side effects, treatment efficacy and patients’ satisfaction with it, and experience using other antimuscarinic treatments. Among the social and economic factors, those with the strongest correlation to compliance were patient age, employment in medicine and education, annual income level, percentage of solifenacin purchase expenditures, and caffeine abuse. Factors with a weaker, but still significant, association were gender, employment in the transportation industry, and monthly income level. |
format | Online Article Text |
id | pubmed-5083827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Korean Continence Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-50838272016-11-01 Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms Kosilov, Kirill Vladimirovich Alexandrovich, Loparev Sergay Gennadyevna, Kuzina Irina Viktorovna, Shakirova Olga Sergeevna, Zhuravskaya Natalia Ivanovich, Ankudinov Ivan Int Neurourol J Original Article PURPOSE: The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the possible impact of a wide range of social, economic, and medical factors on compliance with solifenacin treatment in the working population. METHODS: Social, economic, and medical factors as well as the Overactive Bladder questionnaire – the OAB-q Short Form (OAB-q SF), bladder diaries, and uroflowmetry of 1,038 people who were administered solifenacin for a year were gathered from employer documentation. RESULTS: Among the subjects, 32% maintained their compliance with solifenacin treatment throughout the year. Only 65% of the patients had compliance exceeding 80%, and 17% of patients had compliance of ≥50%, yet less than 80% were still taking solifenacin 12 months after the beginning of this experiment. Working people whose compliance level was, at least, 80% had reliably higher (P≤0.01) average age, annual salary, and treatment efficacy, and a greater treatment satisfaction level, as well as a lack of satisfaction with other antimuscarinic treatments and higher rate of urge UI diagnosis. The same cohort also featured a lower level (P≤0.01) of caffeine abuse and lower share of salary spent purchasing solifenacin. CONCLUSIONS: This study has shown that compliance with solifenacin treatment is associated with a number of significant medical, social, and economic factors. The medical factors included the type of urination disorder, severity of incontinence symptoms, presence of side effects, treatment efficacy and patients’ satisfaction with it, and experience using other antimuscarinic treatments. Among the social and economic factors, those with the strongest correlation to compliance were patient age, employment in medicine and education, annual income level, percentage of solifenacin purchase expenditures, and caffeine abuse. Factors with a weaker, but still significant, association were gender, employment in the transportation industry, and monthly income level. Korean Continence Society 2016-09 2016-09-23 /pmc/articles/PMC5083827/ /pubmed/27706009 http://dx.doi.org/10.5213/inj.1632520.260 Text en Copyright © 2016 Korean Continence Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kosilov, Kirill Vladimirovich Alexandrovich, Loparev Sergay Gennadyevna, Kuzina Irina Viktorovna, Shakirova Olga Sergeevna, Zhuravskaya Natalia Ivanovich, Ankudinov Ivan Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms |
title | Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms |
title_full | Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms |
title_fullStr | Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms |
title_full_unstemmed | Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms |
title_short | Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms |
title_sort | social, economic, and medical factors associated with solifenacin therapy compliance among workers who suffer from lower urinary tract symptoms |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083827/ https://www.ncbi.nlm.nih.gov/pubmed/27706009 http://dx.doi.org/10.5213/inj.1632520.260 |
work_keys_str_mv | AT kosilovkirillvladimirovich socialeconomicandmedicalfactorsassociatedwithsolifenacintherapycomplianceamongworkerswhosufferfromlowerurinarytractsymptoms AT alexandrovichloparevsergay socialeconomicandmedicalfactorsassociatedwithsolifenacintherapycomplianceamongworkerswhosufferfromlowerurinarytractsymptoms AT gennadyevnakuzinairina socialeconomicandmedicalfactorsassociatedwithsolifenacintherapycomplianceamongworkerswhosufferfromlowerurinarytractsymptoms AT viktorovnashakirovaolga socialeconomicandmedicalfactorsassociatedwithsolifenacintherapycomplianceamongworkerswhosufferfromlowerurinarytractsymptoms AT sergeevnazhuravskayanatalia socialeconomicandmedicalfactorsassociatedwithsolifenacintherapycomplianceamongworkerswhosufferfromlowerurinarytractsymptoms AT ivanovichankudinovivan socialeconomicandmedicalfactorsassociatedwithsolifenacintherapycomplianceamongworkerswhosufferfromlowerurinarytractsymptoms |